Evidence map›Paper›PMID 35519592›Full record

ArticleRSC advances2019

A combined experimental and density functional theory study of metformin oxy-cracking for pharmaceutical wastewater treatment.

Ismail Badran, Abdallah D Manasrah, Nashaat N Nassar

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  6. Article
  7. New 1RSC advances · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ismail BadranDepartment of Chemical and Petroleum Engineering, University of Calgary 2500 University Drive NW Calgary Alberta Canada T2N 1N4 nassar@ucalgary.ca +1 403 210 3973 +1 403 210 9772.ORCID https://orcid.org/0000-0003-1423-7124
Abdallah D ManasrahDepartment of Chemical and Petroleum Engineering, University of Calgary 2500 University Drive NW Calgary Alberta Canada T2N 1N4 nassar@ucalgary.ca +1 403 210 3973 +1 403 210 9772.ORCID https://orcid.org/0000-0002-2534-1739
Nashaat N NassarDepartment of Chemical and Petroleum Engineering, University of Calgary 2500 University Drive NW Calgary Alberta Canada T2N 1N4 nassar@ucalgary.ca +1 403 210 3973 +1 403 210 9772.ORCID https://orcid.org/0000-0001-9014-542X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmaceutical compounds are emerging contaminants that have been detected in surface water across the world. Because conventional wastewater treatment plants are not designed to treat such pollutants, new technologies are needed to degrade and oxidize such contaminants. The newly developed oxy-cracking process was utilized to treat the antidiabetic drug, metformin. The process, which involved partial oxidation of metformin in alkaline aqueous medium, proved to decompose the drug into small organic molecules, with minimum emission of CO

Identifiers

PMID35519592
PMCPMC9063927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.